Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Documenting Pharmacogenomic Testing with CPT Codes.

Literature DB >> 27055343

Documenting Pharmacogenomic Testing with CPT Codes.

Erik Hefti, Javier G Blanco.

Abstract

Entities: Disease Species

Mesh：

Year: 2016 PMID： 27055343 PMCID： PMC4998735

Source DB: PubMed Journal: J AHIMA ISSN： 1060-5487

× No keyword cloud information.

11 in total

Review 1. Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice.

Authors: Felix W Frueh
Journal: Pharmacogenomics Date: 2010-05 Impact factor: 2.533

2. Clinical use of pharmacogenomic tests in 2009.

Authors: Leslie J Sheffield; Hazel E Phillimore
Journal: Clin Biochem Rev Date: 2009-05

3. Pharmacogenomics in clinical practice: reality and expectations.

Authors: C Lee Ventola
Journal: P T Date: 2011-07

Review 4. Genomics and drug response.

Authors: Liewei Wang; Howard L McLeod; Richard M Weinshilboum
Journal: N Engl J Med Date: 2011-03-24 Impact factor: 91.245

Review 5. Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.

Authors: Joseph P Kitzmiller; David K Groen; Mitch A Phelps; Wolfgang Sadee
Journal: Cleve Clin J Med Date: 2011-04 Impact factor: 2.321

6. Facilitating clinical implementation of pharmacogenomics.

Authors: David A Mrazek; Caryn Lerman
Journal: JAMA Date: 2011-07-20 Impact factor: 56.272

Review 7. The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis.

Authors: Josh J Carlson; Joshua A Roth
Journal: Breast Cancer Res Treat Date: 2013-08-24 Impact factor: 4.872

8. Insurance coverage policies for personalized medicine.

Authors: Andrew Hresko; Susanne B Haga
Journal: J Pers Med Date: 2012-10-30

9. Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.

Authors: J Winner; J D Allen; C Anthony Altar; A Spahic-Mihajlovic
Journal: Transl Psychiatry Date: 2013-03-19 Impact factor: 6.222

10. A critical analysis of barriers to the clinical implementation of pharmacogenomics.

Authors: Ross A McKinnon; Michael B Ward; Michael J Sorich
Journal: Ther Clin Risk Manag Date: 2007-10 Impact factor: 2.423

5 in total

Review 1. Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.

Authors: Simona Volpi; Carol J Bult; Rex L Chisholm; Patricia A Deverka; Geoffrey S Ginsburg; Howard J Jacob; Melpomeni Kasapi; Howard L McLeod; Dan M Roden; Marc S Williams; Eric D Green; Laura Lyman Rodriguez; Samuel Aronson; Larisa H Cavallari; Joshua C Denny; Lynn G Dressler; Julie A Johnson; Teri E Klein; J Steven Leeder; Micheline Piquette-Miller; Minoli Perera; Laura J Rasmussen-Torvik; Heidi L Rehm; Marylyn D Ritchie; Todd C Skaar; Nikhil Wagle; Richard Weinshilboum; Kristin W Weitzel; Robert Wildin; John Wilson; Teri A Manolio; Mary V Relling
Journal: Clin Pharmacol Ther Date: 2018-03-30 Impact factor: 6.875